Related references
Note: Only part of the references are listed.Guidelines on the Verge of a More Evidence-Based Era for Hypertrophic Cardiomyopathy
Carolyn Y. Ho
CIRCULATION (2021)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
Mikhail N. Kosiborod et al.
CIRCULATION (2020)
Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation
Suzanne V. Arnold et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Study Design and Rationale of EXPLORER-HCM Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Carolyn Y. Ho et al.
CIRCULATION-HEART FAILURE (2020)
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto et al.
LANCET (2020)
Mavacamten: treatment aspirations in hypertrophic cardiomyopathy
Michael Papadakis et al.
LANCET (2020)
Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life
Erica Zaiser et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2020)
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care JACC State-of-the-Art Review
John A. Spertus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Paul A. Heidenreich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Medical Therapy for Heart Failure With Reduced Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Clinical Course and Management of Hypertrophic Cardiomyopathy
Barry J. Maron
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S. Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction A Secondary Analysis of 2 Randomized Clinical Trials
Yashashwi Pokharel et al.
JAMA CARDIOLOGY (2017)
Hypertrophic Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Ali J. Marian et al.
CIRCULATION RESEARCH (2017)
Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience
Hassan Rastegar et al.
ANNALS OF CARDIOTHORACIC SURGERY (2017)
Hypertrophic obstructive cardiomyopathy-the Leipzig experience
Jawad Khalil et al.
ANNALS OF CARDIOTHORACIC SURGERY (2017)
Long-term Clinical Follow-Up of Patients Undergoing Percutaneous Alcohol Septal Reduction for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Silvia Fortunato de Cano et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2016)
Quantifying clinical change: discrepancies between patients' and providers' perspectives
Rachel P. Dreyer et al.
QUALITY OF LIFE RESEARCH (2016)
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Eric M. Green et al.
SCIENCE (2016)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy
Christopher M. Huff et al.
QUALITY OF LIFE RESEARCH (2013)
Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure
Kathryn E. Flynn et al.
AMERICAN HEART JOURNAL (2012)
Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis Results From the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)
Matthew R. Reynolds et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Patient Health Status and Costs in Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Paul S. Chan et al.
CIRCULATION (2009)
Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments
Mikhail Kosiborod et al.
CIRCULATION (2007)
Health status identifies heart failure outpatients at risk for hospitalization or death
PA Heidenreich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Monitoring clinical changes in patients with heart failure: A comparison of methods
J Spertus et al.
AMERICAN HEART JOURNAL (2005)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic value of health status in patients with heart failure after acute myocardial infarction
GE Soto et al.
CIRCULATION (2004)
Helping patients follow prescribed treatment - Clinical applications
RB Haynes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
